מסנה-סל 400 מ"ג - Mesna-cell 400 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | V03AF Detoxifying agents for antineoplastic treatment | |||||
|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-×ר××× - I.V | |||||
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Prevention of urinary tract toxicity of oxazaphosphorines (the active components of Ifosfamide, Cyclophosphamide , Trofosfamide) in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, Cyclophosphamide or Trofosfamide, urinary passage diseases in anamnesis. | |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ××¡× ×-×¡× 100 ×"× /×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | STADAPHARM GMBH, GERMANY |
| ×©× ××¢× ×ר×ש×× | MBI PHARMA LTD., ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 03/2014. ר×ש××× ×ת×ר××: 07/2015 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |